It has been reported that the deletion of the GSTM1 and GSTT1 gene as well as the variant allele of the GSTP1 rs1695 polymorphism impact overall breast cancer risk (Steck et al., 2007). This evidence concerns the gene GSTM1 and breast carcinoma.